Who owns ICU MEDICAL INC/DE (ICUI)? Elite investor 13F holders
3 tracked elite investors reported holding ICU MEDICAL INC/DE as of 2026-06-30, including Gotham Asset Management, GAMCO, D.E. Shaw. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Health Care Equipment & Services
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Gotham Asset Management | ICU MED INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 2827767.00 USD | 19289.000000 | Shares | reduce | Original filing |
| GAMCO | ICU MED INC | SHARE | 2026-06-30 | 2026-08-12 00:00:00 | 3505499.00 USD | 23912.000000 | Shares | reduce | Original filing |
| D.E. Shaw | ICU MED INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 2943142.00 USD | 20076.000000 | Shares | buy | Original filing |
| Renaissance Technologies LLC | ICU MED INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.